FHD-286 in Subjects With Metastatic Uveal Melanoma
Condition: Metastatic Uveal Melanoma Intervention: Drug: FHD-286 Sponsors: Foghorn Therapeutics Inc.; Syneos Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2021 Category: Research Source Type: clinical trials